Quintiles, Inc. And Movetis Announce Strategic Alliance to Launch Gastrointestinal Product
Published: Jan 28, 2010
RESEARCH TRIANGLE PARK, N.C. & TURNHOUT, Belgium--(BUSINESS WIRE)--Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance. The agreement is expected to be extended later this year to cover other selected European countries.